Why To Keep Buying Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) while S&P500 loss -1.67%
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) has a beta of 1.77. The stock’s Relative Strength Index (RSI) is 50.60, with weekly volatility at 5.31% and ATR